In this study, we employed the two most widely adopted in vitro models of PD, 6-OHDA- and MPP+-treated SH-SY5Y cells, to systematically compare their cellular effects with a particular emphasis on GPL metabolism. The gene discussed is IL31RA; the disease is Parkinson disease.